Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Roche Sheds Small Molecule Manufacturing


Cuts will affect 1,200 jobs at Swiss drug firm

by Lisa M. Jarvis
November 12, 2015

Citing underutilized capacity, Roche has announced a major overhaul of its manufacturing network. In a move that will affect 1,200 jobs, the Swiss pharma firm is shedding four manufacturing sites, located in Clarecastle, Ireland; Leganes, Spain; Segrate, Italy; and Florence, S.C. Roche will meanwhile sink roughly $300 million into a site in Kaiseraugst, Switzerland, to support novel manufacturing technology. Roche, which hopes to find a buyer for the facilities, expects to incur restructuring costs will total $1.6 billion between 2016 and 2021. As it pares back its small molecule manufacturing, Roche notes that it has put more than $2 billion into biologics manufacturing capacity in the past two years.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.